Carcinoma, Basal Cell Clinical Trial
Official title:
Early Detection of Skin Cancer Using Millimetre-Wave Waveguide Reflectometers
Verified date | November 2018 |
Source | Lawson Health Research Institute |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Skin cancer represents a large problem in today's healthcare setting. The majority of cancer diagnoses are attributed to malignant skin diseases including its major types: basal cell carcinoma, squamous cell carcinoma and melanoma. Early diagnoses is critical given early detection of malignant lesions largely increases chances of successful treatment. The current gold standard of diagnosis is histopathological examination of biopsied skin. Biopsies are not only invasive and expensive, they have variable positive predictive value, meaning they may often be preformed unnecessarily. As such, the investigators have developed a skin scanner, which is less bulky and expensive than existing similar technologies, as a tool to evaluate skin lesions prior to determining the need for a biopsy. Their objective is to obtain information in order to validate this skin scanner in the context of its ability to accurately identify basal cell carcinoma skin lesions.
Status | Completed |
Enrollment | 60 |
Est. completion date | February 2018 |
Est. primary completion date | February 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Inclusion Criteria: - Patient requiring skin biopsy for suspected basal cell carcinoma skin lesion - 18 years of age or older Exclusion Criteria: -Poor english fluency, Pregnancy |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Lawson Health Research Institute |
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Positive predictive value | Immediately pre-biopsy |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT00875381 -
Analysis of Melanocytes (Pigment Cells) in Sun-Exposed Skin
|
N/A | |
Recruiting |
NCT04362722 -
Intratumoral Administration of Daromun in Non-melanoma Skin Cancer Patients
|
Phase 2 | |
Completed |
NCT00218829 -
DMSO-PDT of BCC - A 6 Year Follow up
|
N/A | |
Completed |
NCT02674009 -
Observational Study to Determine the Effectiveness and Safety of Vismodegib (Erivedge®) in Participants With Locally Advanced Basal Cell Carcinoma (laBCC)
|
||
Recruiting |
NCT05970497 -
A Study Assessing KB707 for the Treatment of Locally Advanced or Metastatic Solid Tumors
|
Phase 1 | |
Terminated |
NCT02956889 -
To Assess The Efficacy And Safety Of Vismodegib And Radiotherapy In Advanced Basal Cell Carcinoma
|
Phase 2 | |
Completed |
NCT01204073 -
A Study of TAK-441 in Adult Patients With Advanced Nonhematologic Malignancies
|
Phase 1 | |
Completed |
NCT02029352 -
Topical Green Tea Ointment in Treatment of Superficial Skin Cancer
|
Phase 2/Phase 3 | |
Completed |
NCT03569345 -
Basal Cell Carcinomas Treated With Ablative Fractional Laser and Ingenol Mebutate
|
Phase 1/Phase 2 | |
Recruiting |
NCT05463757 -
Oral Hedgehog Inhibitors in the Treatment of Basal Cell Carcinoma in the Netherlands: a Prospective Registration Study
|
||
Completed |
NCT00189280 -
Aldara for the Treatment of Large and/or Multiple sBCC
|
Phase 3 | |
Completed |
NCT03541252 -
Topical Laser-assisted Combination Chemotherapy for Basal Cell Carcinoma- a Clinical Study
|
Phase 1/Phase 2 | |
Recruiting |
NCT05133427 -
HIFU for Treatment of Non-nodular and Recurrent BCC
|
N/A | |
Active, not recruiting |
NCT02367547 -
Superficial Basal Cell Cancer's Photodynamic Therapy: Comparing Three Photosensitizers: HAL and BF-200 ALA Versus MAL
|
Phase 1/Phase 2 | |
Completed |
NCT00007631 -
Determine the Efficacy of Topical Tretinoin Cream for the Prevention of Nonmelanoma Skin Cancer
|
Phase 3 | |
Active, not recruiting |
NCT05138328 -
Laser Treatment of Basal Cell Carcinoma Under Imaging Guidance
|
N/A | |
Completed |
NCT03132636 -
PD-1 in Patients With Advanced Basal Cell Carcinoma Who Experienced Progression of Disease on Hedgehog Pathway Inhibitor Therapy, or Were Intolerant of Prior Hedgehog Pathway Inhibitor Therapy
|
Phase 2 | |
Completed |
NCT00847912 -
CSP #562 - The VA Keratinocyte Carcinoma Chemoprevention Trial
|
Phase 4 | |
Enrolling by invitation |
NCT02666833 -
Optical Imaging for Preoperative Delineation of Nonmelanoma Skin Cancers
|
N/A | |
Completed |
NCT01482104 -
New Versus Approved Methyl-aminolevulinate Photodynamic Therapy (MAL-PDT) Regime in Basal Cell Carcinoma (BCC)
|
N/A |